The puzzling situation of hospital exemption for advanced therapy medicinal products in Europe and stakeholders' concerns

被引：35
|
作者：
Cuende, Natividad [1 ]
Boniface, Christelle [2 ]
Bravery, Christopher [3 ]
Forte, Miguel [2 ]
Giordano, Rosaria [4 ]
Hildebrandt, Martin [5 ]
Izeta, Ander [6 ]
Dominici, Massimo [7 ]
机构：
[1] Junta Andalucia, Serv Andaluz Salud, Andalusian Initiat Adv Therapies, Seville, Spain
[2] TxCell SA, Valbonne, Sophia Antipoli, France
[3] Consulting Adv Biol Ltd, London, England
[4] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy
[5] Tech Univ Munich, TUMCells Interdisciplinary Ctr Cellular Therapie, D-80290 Munich, Germany
[6] Hosp Univ Donostia, Inst Biodonostia, Tissue Engn Lab, San Sebastian, Spain
[7] Univ Hosp Modena & Reggio Emilia, Lab Cell Biol & Adv Canc Therapies, Modena, Italy
来源：
CYTOTHERAPY | 2014年 / 16卷 / 12期
关键词：
MARROW MONONUCLEAR-CELLS;
D O I：
10.1016/j.jcyt.2014.08.007
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：1597 / 1600
页数：4
相关论文
共 50 条
  • [21] MARKET ACCESS TRENDS FOR ADVANCED THERAPY MEDICINAL PRODUCTS (ATMPS) IN EUROPE
    Dellamano, R.
    Mycka, J.
    Lobb, W.
    Dellamano, L.
    Dalal, N.
    VALUE IN HEALTH, 2018, 21 : S465 - S465
  • [22] Advanced therapy medicinal products
    Lozano-Blazquez, Ana
    Makridaki, Despina
    Plesan, Claudia Roxana
    Kohl, Stephanie
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2024, 31 (01) : 63 - 65
  • [23] Advanced therapy medicinal products
    Seitz, R.
    Schneider, C. K.
    Hengel, H.
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2011, 54 (07) : 789 - 790
  • [24] Role of Hospital Exemption in Europe: position paper from the Spanish Advanced Therapy Network (TERAV)
    Fermín Sánchez-Guijo
    Cristina Avendaño-Solá
    Lina Badimón
    Juan A. Bueren
    Josep M. Canals
    Joaquim Delgadillo
    Julio Delgado
    Cristina Eguizábal
    María-Eugenia Fernández-Santos
    Damián García-Olmo
    Gloria González-Aseguinolaza
    Manel Juan
    Francisco Martín
    Rosario Mata
    Nuria Montserrat
    Antonio Pérez-Martínez
    José A. Pérez-Simón
    Felipe Prósper
    Álvaro Urbano-Ispizua
    Agustín G. Zapata
    Anna Sureda
    José M. Moraleda
    Bone Marrow Transplantation, 2023, 58 : 727 - 728
  • [25] Role of Hospital Exemption in Europe: position paper from the Spanish Advanced Therapy Network (TERAV)
    Sanchez-Guijo, Fermin
    Avendano-Sola, Cristina
    Badimon, Lina
    Bueren, Juan A.
    Canals, Josep M.
    Delgadillo, Joaquim
    Delgado, Julio
    Eguizabal, Cristina
    Fernandez-Santos, Maria-Eugenia
    Garcia-Olmo, Damian
    Gonzalez-Aseguinolaza, Gloria
    Juan, Manel
    Martin, Francisco
    Mata, Rosario
    Montserrat, Nuria
    Perez-Martinez, Antonio
    Perez-Simon, Jose A.
    Prosper, Felipe
    Urbano-Ispizua, Alvaro
    Zapata, Agustin G.
    Sureda, Anna
    Moraleda, Jose M.
    BONE MARROW TRANSPLANTATION, 2023, 58 (06) : 727 - 728
  • [26] Advanced therapy medicinal products' (ATMP) pharmaceutical circuit in France: Current situation and outlook
    Fabri, Benjamin
    Sicard, Guillaume
    Gauthier-Villano, Laurence
    Pourroy, Bertrand
    ANNALES PHARMACEUTIQUES FRANCAISES, 2023, 81 (06): : 1038 - 1053
  • [27] THE CHALLENGES OF OUTCOMES-BASED REIMBURSEMENT FOR ADVANCED THERAPY MEDICINAL PRODUCTS IN EUROPE
    Wallace, M.
    Redman, N.
    VALUE IN HEALTH, 2022, 25 (12) : S251 - S251
  • [28] Whither Advanced Therapy Medicinal Products?
    Smith, Mark D.
    Brune, Jan C.
    Wildemann, Britt
    Pruss, Axel
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2013, 40 (06) : 449 - 452
  • [29] The certification of advanced therapy medicinal products
    Berger, A.
    Schuele, S.
    Flory, E.
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2011, 54 (07) : 816 - 821
  • [30] Advanced therapy medicinal products in surgery
    Wigmore, Stephen J.
    BRITISH JOURNAL OF SURGERY, 2022, 109 (11) : 1027 - 1029
12345